mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.6 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |